What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Understand the ideal retirement savings amount to help you plan effectively for your future. Let's secure your finances!
10,154 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
A growing wave of market voices warns that the flood of easy investing access can erode returns. Carlson says many in...
On-chain tokenized real-world assets approach $30 billion, but DeFi liquidity trails far behind, underscoring uneven ...
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
Bitcoin has moved sharply after its peak, creating a dilemma for investors. This guide breaks down what bitcoin after...
With summer on the horizon, investors wonder if XLE should ride along in their portfolios. This guide weighs the case...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
GraniteShares’ 2x COIN ETF has seen substantial NAV erosion as Coinbase volatility spikes, prompting renewed debate o...
This week’s rally in First Solar stock is turning heads. We break down the catalysts, assess risks, and offer practic...
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
A small BTC sale by Strategy is not a capitulation. The firm says the move funds preferred stock distributions while ...